Back to funds
View filing
Davern Capital Partners, LP
hedge fundUpdated 28 days agoManaged by Davern Capital Partners, Lp • Latest filing Q2 2026
Portfolio value
$586.5M
Q2 2026
Filings
3
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 3 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $309.3M |
| Q1 2026 | $364.5M |
| Q2 2026 | $586.5M |
Top holdings
15 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | B BNTX BIONTECH SE | $70.2M | 754.5K | 11.97% | — |
| 2 | R ROIV ROIVANT SCIENCES LTD | $68.4M | 1.93M | 11.66% | — |
| 3 | R RPRX ROYALTY PHARMA PLC | $64.8M | 1.16M | 11.05% | — |
| 4 | I IONS IONIS PHARMACEUTICALS INC | $63.3M | 798.7K | 10.80% | — |
| 5 | I INSM INSMED INC | $59.7M | 559.8K | 10.18% | — |
| 6 | R REGN REGENERON PHARMACEUTICALS | $57.8M | 92.6K | 9.85% | — |
| 7 | L LEGN LEGEND BIOTECH CORP | $34.4M | 1.19M | 5.87% | — |
| 8 | A ALNY ALNYLAM PHARMACEUTICALS INC | $34M | 113.1K | 5.80% | — |
| 9 | N NTRA NATERA INC | $32.3M | 119.0K | 5.51% | — |
| 10 | G GPCR STRUCTURE THERAPEUTICS INC | $23.9M | 446.1K | 4.08% | — |
| 11 | M MLYS MINERALYS THERAPEUTICS INC | $23.2M | 858.8K | 3.95% | — |
| 12 | V VERA VERA THERAPEUTICS INC | $21.4M | 498.8K | 3.65% | — |
| 13 | G GENB GENERATE BIOMEDICINES INC | $13.9M | 824.7K | 2.37% | — |
| 14 | P PRCT PROCEPT BIOROBOTICS CORP | $10.5M | 464.9K | 1.79% | — |
| 15 | ? N/A AVALO THERAPEUTICS INC | $8.7M | 468.7K | 1.48% | — |